Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort

Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort

Abstract Background Low doses of febuxostat or benzbromarone are widely used in Asian countries, but lacking studies to compare the efficacy and safety of the two urate-lowering drugs. Methods To compare the efficacy and safety of low-dose febuxostat with low-dose benzbromarone in patients with prim...

Full description

Bibliographic Details
Main Authors: Nan Liang, Mingshu Sun, Ruixia Sun, Ting Xu, Lingling Cui, Can Wang, Lidan Ma, Xiaoyu Cheng, Xiaomei Xue, Wenyan Sun, Xuan Yuan, Hui Zhang, Hailong Li, Yuwei He, Aichang Ji, Xinjiang Wu, Changgui Li
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Arthritis Research & Therapy
Subjects:
Gout
Benzbromarone
Febuxostat
Urate-lowering treatment
Online Access:http://link.springer.com/article/10.1186/s13075-019-1976-x

Internet

http://link.springer.com/article/10.1186/s13075-019-1976-x

Similar Items